May 16th 2024
Data from a meta-analysis of evinacumab trials reveal significant reductions in cholesterol and other lipid markers among patients with dyslipidemia.
Thyroid Analogue Reduces Cholesterol without Heart, Bone Risks
March 15th 2010In a phase II study, eprotirome was shown to be both safe and effective in lowering cholesterol without classic thyroid risks, however it is not known whether this lowering of cholesterol will ultimately protect patients from heart disease.
Exposure to Tobacco Smoke in Adolescence Leads to Arterial Changes associated with Atherosclerosis
March 5th 2010Although previous research has been conducted about the relationship between tobacco smoke and atherosclerosis in adults, a new study is one of the first about the correlation in children.
Exercise in Young Obese Children Reduces Blood Pressure, Improves Markers of Atherosclerosis
December 31st 2009This online CME program is based on a study that appeared online December 11, 2009 in the Journal of the American College of Cardiology, and is designed for primary care clinicians, cardiologists, endocrinologists, and other specialists who care for obese children.
The prognostic role of metabolic syndrome after myocardial infarction
September 24th 2008We evaluated the prognostic role of metabolic syndrome after myocardial infarction and found that metabolic syndrome correlated with an increased risk of cardiovascular events and death. The risk of developing diabetes decreased with weight loss in patients with metabolic syndrome. These results indicate that a more aggressive approach to the treatment of patients with metabolic syndrome, particularly with regard to changes in lifestyle, would be beneficial.
Thoracic and abdominal aorticatherosclerosis
It was not until Virchow identified the cellular contributions to thrombosis that physicians began to visualize arteries as dynamic tissues.